IL1B and monocytic leukemia: In the human monocytic leukemia cell line THP-1, used for inflammasome/pyroptosis studies (31), CLM increased release of IL-1β and active caspase-1 (compared with ATP) already 3 hours after activation (Figure 2, A and C, Supplemental Figure 1A, respectively).